Skip to main content
. 2018 Dec 25;85(6):1169–1179. doi: 10.1111/bcp.13820

Figure 2.

Figure 2

Current and future targets in the treatment of fibrous dysplasia. FGF‐23, fibroblast growth factor‐23; anti‐NGF, anti‐nerve growth factor; BMSC, bone marrow stromal cells